Cargando…
491: Prospective Evaluation of nontuberculous mycobacterial Disease in Cystic fibrosis Trial (PREDICT): Colorado single center (2013–2018)
Autores principales: | Martiniano, S., Anthony, M., Vu, P., Khan, U., Xie, J., Wagner, B., Nichols, D., Jones, M., Lovell, V., Nick, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Cystic Fibrosis Society.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518469/ http://dx.doi.org/10.1016/S1569-1993(21)01915-9 |
Ejemplares similares
-
Nontuberculous mycobacterial infection and environmental molybdenum in persons with cystic fibrosis: a case–control study in Colorado
por: Lipner, Ettie M., et al.
Publicado: (2021) -
Nontuberculous Mycobacterial Disease and Molybdenum in Colorado Watersheds
por: Lipner, Ettie M., et al.
Publicado: (2020) -
Investigating Nontuberculous Mycobacteria Transmission at the Colorado Adult Cystic Fibrosis Program
por: Gross, Jane E., et al.
Publicado: (2022) -
Sputum Metabolites Associated with Nontuberculous Mycobacterial Infection in Cystic Fibrosis
por: Breen, Paul, et al.
Publicado: (2022) -
Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection
por: Caverly, Lindsay J., et al.
Publicado: (2021)